NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that its DERMAdoctor product collections will be featured at Cosmoprof North America, a leading business-to-business (B2B) beauty trade show being held July 12-14 at the Las Vegas Convention Center.
“We’re thrilled about connecting in-person with retailers and other professionals at the most important beauty industry networking opportunity held annually in the U.S.,” said Audrey Kunin, MD, NovaBay’s Chief Product Officer and a board-certified dermatologist. “The DERMAdoctor team will be showcasing products that offer innovative treatments that address commonly overlooked skin concerns and target specific underserved segments of the skincare market. Each formulation is designed to be elegant, hypoallergenic and highly effective while addressing multiple customer needs, all without the need for a prescription. We invite retailers to explore our DERMAdoctor collections and meet with us at booth 34050 on the exhibition floor.”
DERMAdoctor manufactures, distributes and sells more than 30 products under various collection brands that include Ain’t Misbehavin’, Calm Cool + Corrected, Kakadu C, KP Duty and Wrinkle Revenge. Its products are designed to address acne, aging skin, dark spots, dry skin, eczema, fine lines and wrinkles, enlarged pores, hyperhidrosis, keratosis pilaris, oily skin and rosacea, including for those with sensitive skin. All DERMAdoctor products are cosmetically appealing and clinically proven without the use of animal testing.
DERMAdoctor sells its products through major retailers such as Macy’s, QVC and Costco, as well as through digital beauty retailers including SkinStore, Amazon.com and its own DERMAdoctor.com website. DERMAdoctor products are also available internationally through select distributors and retailers.
About Cosmoprof North America
Cosmoprof North America is recognized for its dynamic growth and unique programs in an event that offers the entire beauty industry an opportunity to come together, forge new relationships with top industry professionals and retailers and foster collaboration. The trade show is a powerful platform that has enjoyed the continuous support and presence of key industry entities and leading beauty associations. It provides a forum for launching new products, discovering unique brands and showcasing product innovation, packaging, manufacturing and new distribution channels. More information is available here.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray and DERMAdoctor is a premium skincare brand offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.
NovaBay Pharmaceuticals Forward-Looking Statements
Except for historical information herein, matters set forth in this press release may be forward looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial progress and future financial performance of NovaBay Pharmaceuticals, Inc. This release contains forward-looking statements that are based upon management’s current expectations, assumptions, estimates, projections and beliefs. These statements include, but are not limited to, statements regarding our business strategies as well as generally the Company’s expected future financial results. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by the forward-looking statements. Other risks relating to NovaBay’s business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this press release, are detailed in NovaBay’s latest Form 10-Q/K filings and Registration Statement on Form S-1 filing with the Securities and Exchange Commission, especially under the heading “Risk Factors.” The forward-looking statements in this release speak only as of this date, and NovaBay disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.